🇺🇸 FDA
Patent

US 9290562

Transferrin-tumstatin fusion protein and methods for producing and using the same

granted A61KA61K38/00A61P

Quick answer

US patent 9290562 (Transferrin-tumstatin fusion protein and methods for producing and using the same) held by The Regents of the University of Colorado expires Mon Mar 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado
Grant date
Tue Mar 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K38/00, A61P, A61P27/02, A61P35/00